{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:33:34Z","timestamp":1781602414927,"version":"3.54.5"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,12]],"date-time":"2013-08-12T00:00:00Z","timestamp":1376265600000},"content-version":"vor","delay-in-days":345,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.bjid.2012.05.002","type":"journal-article","created":{"date-parts":[[2012,11,2]],"date-time":"2012-11-02T11:34:59Z","timestamp":1351856099000},"page":"448-451","source":"Crossref","is-referenced-by-count":4,"title":["Thyroid dysfunction in Turkish patients with chronic hepatitis C receiving peginterferon plus ribavirin in the period of 2005-2010"],"prefix":"10.1016","volume":"16","author":[{"given":"Sener","family":"Barut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Gunal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unal","family":"Erkorkmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feyza","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2012.05.002_bib0005","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bjid.2012.05.002_bib0010","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.autrev.2004.03.003","article-title":"Interferon induced autoimmune thyroid disease (AITD): a model for human autoimmunity","volume":"3","author":"Oppenheim","year":"2004","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.bjid.2012.05.002_bib0015","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1590\/S1413-86702008000200009","article-title":"Thyroid dysfunction in hepatitis C individuals treated with interferon-alpha and ribavirin \u2014 a review","volume":"12","author":"Andrade","year":"2008","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.bjid.2012.05.002_bib0020","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1440-1746.2009.05874.x","article-title":"Development of thyroid diseases in the treatment of chronic hepatitis C with alpha-interferon may be a good prognosticator in achieving a sustained virological response: a meta-analysis","volume":"24","author":"Tran","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.bjid.2012.05.002_bib0025","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1007\/s00705-004-0363-2","article-title":"Molecular epidemiology of hepatitis B, C and D viruses in Turkish patients","volume":"149","author":"Bozdayi","year":"2004","journal-title":"Arch Virol"},{"key":"10.1016\/j.bjid.2012.05.002_bib0030","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/gut.2005.076646","article-title":"Treating viral hepatitis C: efficacy, side effects and complications","volume":"55","author":"Manns","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.bjid.2012.05.002_bib0035","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1136\/bmj.332.7548.1013","article-title":"Diagnosis and treatment of chronic hepatitis C infection","volume":"332","author":"Patel","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.bjid.2012.05.002_bib0040","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1046\/j.1365-2796.2002.00974.x","article-title":"Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy","volume":"251","author":"Dalgard","year":"2002","journal-title":"J Intern Med"},{"key":"10.1016\/j.bjid.2012.05.002_bib0045","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1440-1746.2009.05812.x","article-title":"Thyroid dysfunction in patients with chronic hepatitis C: virus- or therapy-related?","volume":"24","author":"Vezali","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.bjid.2012.05.002_bib0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2265.2007.03009.x","article-title":"Thyroid function and anti-thyroid autoantibodies in untreated children with vertically acquiredchronic hepatitis C virus infection","volume":"68","author":"Indolfi","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.bjid.2012.05.002_bib0055","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1440-1746.2008.05690.x","article-title":"Interferon-induced thyroid dysfunction in chronic hepatitis C","volume":"24","author":"Jamil","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.bjid.2012.05.002_bib0060","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1440-1746.2006.04771.x","article-title":"Pegylated interferon-alpha2beta in combination with ribavirin does not aggravate thyroid dysfunction in comparison to regular interferon-alpha2beta in a hepatitis C population: meta-analysis","volume":"22","author":"Tran","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.bjid.2012.05.002_bib0065","first-page":"28","article-title":"Side effects of therapy for chronic hepatitis C: high incidence of dermal and mucosal adverse events","volume":"15","author":"Barut","year":"2010","journal-title":"Flora the Journal of Infectious Diseases and Clinical Microbiology"},{"key":"10.1016\/j.bjid.2012.05.002_bib0070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/qjmed\/hcn150","article-title":"The natural history of interferon-alpha2b-induced thyroiditis and its exclusivity in a cohort of patients with chronic hepatitis C infection","volume":"102","author":"Tran","year":"2009","journal-title":"QJM"},{"key":"10.1016\/j.bjid.2012.05.002_bib0075","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jaut.2009.11.008","article-title":"Hepatitis C and interferon induced thyroiditis","volume":"34","author":"Tomer","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.bjid.2012.05.002_bib0080","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.beem.2009.07.004","article-title":"Interferon induced thyroiditis","volume":"23","author":"Tomer","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.bjid.2012.05.002_bib0085","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1440-1746.2009.05853.x","article-title":"Interferon-induced thyroid dysfunction - not always transient","volume":"24","author":"Wong","year":"2009","journal-title":"J Gastroenterol Hepatol"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867012001316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867012001316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T16:00:20Z","timestamp":1540137620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867012001316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1413867012001316"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2012.05.002","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}